HD-P023

HD-P023 · Handok Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HD-P023, covering 2025-02-04 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers [Phase 1]

See pricing